A U.S. study found that a combination of nine single-nucleotide polymorphisms, previously linked with cholesterol levels, are tied to an elevated risk of cardiovascular events, such as heart attack and stroke. The discovery of the gene variants could help predict who is most likely to benefit from earlier use of cholesterol-lowering drugs and intense monitoring, the researchers said.

Full Story:

Related Summaries